Ardelyx Reports Q1 2026 Earnings and Business Update

Ardelyx (ARDX) reported strong first-quarter performance in 2026 with a 58% year-over-year revenue growth for Ibsrela. The company emphasized its strategic priorities, including accelerating the growth of Ibsrela, maintaining momentum with Exposa, expanding its pipeline, and delivering financial results.

By Motley Fool Transcribing, The Motley Fool Fri, May 1, 2026 at 2:32 AM GMT+3 42 min read · Yahoo Finance ·

Ardelyx Reports Q1 2026 Earnings and Business Update

Tickers: $ARDX

Topics: commercial_strategy earnings pharmaceuticals pipeline revenue_growth

Read the full article at Yahoo Finance

More World news